Time to treatment intensification with GLP-1 receptor agonists for patients with type 2 diabetes in the UK: medical record review study

被引：0
|
作者：
Norrbacka, K. [1 ]
Stein, D. [2 ]
Matza, L. S. [3 ]
Jordan, J. B. [3 ]
Garcia-Perez, L. -E. [4 ]
Hassan, S. W. [4 ]
Boye, K. S. [4 ]
机构：
[1] Eli Lilly Finland, Helsinki, Finland
[2] Evidera, London, England
[3] Evidera, Bethesda, MD USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
746
引用
收藏
页码：S363 / S364
页数：2
相关论文
共 50 条
  • [41] Baseline Characteristics of Patients with Type 2 Diabetes Initiating Sitagliptin or GLP-1 Receptor Agonists
    Brodovicz, Kimberly G.
    Ritchey, Mary E.
    Chen, Yong
    Senderak, Michael
    Liao, Jane
    Girman, Cynthia J.
    Shankar, Ravi
    Liu, Zhiwen
    Engel, Samuel S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 196 - 196
  • [42] Canagliflozin as a replacement therapy for patients with type 2 diabetes not responding to GLP-1 receptor agonists
    Garcia de Lucas, M. D.
    Olalla Sierra, J.
    DIABETES & METABOLISM, 2017, 43 (04) : 373 - 374
  • [43] GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes
    Monney, Marine
    Jornayvaz, Francois R.
    Gariani, Karim
    DIABETES & METABOLISM, 2023, 49 (05)
  • [44] Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists
    Ashruf, Omer S.
    Hundal, Jasmin
    Mushtaq, Ali
    Kaelber, David C.
    Anwer, Faiz
    Singh, Abhay
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [45] Effectiveness and Tolerability Profile of GLP-1 Receptor Agonists in Elderly Patients with Type 2 Diabetes
    Gorgojo-Martinez, Juan J.
    Feo-Ortega, Gara
    Serrano-Moreno, Clara
    Sanz-Velasco, Alberto
    DIABETES, 2016, 65 : A573 - A573
  • [46] GLP-1 receptor agonists and cirrhosis risk in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGIE, 2024, 20 (08): : 897 - 898
  • [47] The role of GLP-1 receptor agonists in managing type 2 diabetes br
    Nachawi, Noura
    Rao, Pratibha P. R.
    Makin, Vinni
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2022, 89 (08) : 457 - 464
  • [48] GLP-1 agonists in type 1 diabetes
    Pettus, Jeremy
    Hirsch, Irl
    Edelman, Steven
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 317 - 323
  • [49] Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naive type 2 diabetes patients in the UK
    Gelhorn, Heather L.
    Poon, Jiat-Ling
    Davies, Evan W.
    Paczkowski, Rosirene
    Curtis, Sarah E.
    Boye, Kristina S.
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 1611 - 1622
  • [50] Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison
    Jung, Han Na
    Cho, Yun Kyung
    Min, Se Hee
    Kim, Hwi Seung
    Kim, Ye-Jee
    Park, Joong-Yeol
    Lee, Woo Je
    Jung, Chang Hee
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345